Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Sensei Biotherapeutics, Inc. (SNSE) had Weighted-Average Shares Outstanding (Diluted) of 1.26M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-6.86M |
|
-- |
|
-- |
|
$7.27M |
|
$-7.27M |
|
$0.41M |
|
$-6.86M |
|
$-6.88M |
|
$-6.86M |
|
$-6.86M |
|
$-6.86M |
|
$-6.88M |
|
$-7.27M |
|
$-7.24M |
|
1.26M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
1.26M |
$-5.40 |
|
$-5.40 |
|
| Balance Sheet Financials | |
$35.68M |
|
$0.16M |
|
$2.59M |
|
$38.27M |
|
$5.23M |
|
$0.04M |
|
$1.06M |
|
$6.29M |
|
$31.99M |
|
$31.99M |
|
$31.99M |
|
1.26M |
|
| Cash Flow Statement Financials | |
$-7.09M |
|
$7.19M |
|
$-0.21M |
|
$9.99M |
|
$9.88M |
|
$-0.12M |
|
$0.46M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.82 |
|
-- |
|
-- |
|
0.00 |
|
0.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.05M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-21.46% |
|
-21.46% |
|
-17.93% |
|
-21.44% |
|
$25.38 |
|
$-5.60 |
|
$-5.63 |
|